Psoriasis and Its Treatment with New Generation Biologics

By: Sangeeta Chakraborty, Ph.D. | Research Associate at National Jewish Health Overview Psoriasis is one of the most common non-communicable skin disorders with a worldwide prevalence of about 2% but can vary from 0.5 to 11%, depending on the geographic region. Since psoriasis pathogenesis is quite complex and the exact mechanisms of its cause are …

Biologic Therapy During COVID-19 

Shifting the model of healthcare around the world, the novel coronavirus (COVID-19) outbreak has significantly impacted the practice of medicine across all specialties, including dermatology and aesthetic medicine. The latest available knowledge suggests that certain demographics may face an increased risk of COVID-19 infection and serious illness, including elderly individuals, those with underlying medical conditions, …